4 research outputs found
“On Water” Direct C‑3 Arylation of 2<i>H</i>‑Pyrazolo[3,4‑<i>b</i>]pyridines
An
“on water” palladium-catalyzed direct (hetero)arylation
of 2<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridines has
been developed. The reactions proceeds smoothly with at low catalytic
loading at low temperature providing the C3 (hetero)arylated products
in good to excellent isolated yields. Free <i>NH</i> 3-arylated
7-azaindazoles were also prepared by simple cleavage of the <i>N</i>-protected groups
Isoquinoline-Based Lanthanide Complexes: Bright NIR Optical Probes and Efficient MRI Agents
In the objective of developing ligands that simultaneously
satisfy the requirements for MRI contrast agents and near-infrared
emitting optical probes that are suitable for imaging, three isoquinoline-based
polyaminocarboxylate ligands, <b>L1</b>, <b>L2</b> and <b>L3</b>, have been synthesized and the corresponding Gd<sup>3+</sup>, Nd<sup>3+</sup> and Yb<sup>3+</sup> complexes investigated. The
specific challenge of the present work was to create NIR emitting
agents which (i) have excitation wavelengths compatible with biological
applications and (ii) are able to emit a sufficient number of photons
to ensure sensitive NIR detection for microscopic imaging. Here we
report the first observation of a NIR signal arising from a Ln<sup>3+</sup> complex in aqueous solution in a microscopy setup. The lanthanide
complexes have high thermodynamic stability (log <i>K</i><sub>LnL</sub> =17.7–18.7) and good selectivity for lanthanide
ions versus the endogenous cations Zn<sup>2+</sup>, Cu<sup>2+</sup>, and Ca<sup>2+</sup> thus preventing transmetalation. A variable
temperature and pressure <sup>17</sup>O NMR study combined with nuclear
magnetic relaxation dispersion measurements yielded the microscopic
parameters characterizing water exchange and rotation. Bishydration
of the lanthanide cation in the complexes, an important advantage
to obtain high relaxivity for the Gd<sup>3+</sup> chelates, has been
demonstrated by <sup>17</sup>O chemical shifts for the Gd<sup>3+</sup> complexes and by luminescence lifetime measurements for the Yb<sup>3+</sup> analogues. The water exchange on the three Gd<sup>3+</sup> complexes is considerably faster (<i>k</i><sub>ex</sub><sup>298</sup> = (13.9–15.4) × 10<sup>6</sup> s<sup>–1</sup>) than on commercial Gd<sup>3+</sup>-based contrast agents and proceeds <i>via</i> a dissociative mechanism, as evidenced by the large
positive activation volumes for Gd<b>L1</b> and Gd<b>L2</b> (+10.3 ± 0.9 and +10.6 ± 0.9 cm<sup>3</sup> mol<sup>–1</sup>, respectively). The relaxivity of Gd<b>L1</b> is doubled at
40 MHz and 298 K in fetal bovine serum (<i>r</i><sub>1</sub> = 16.1 vs 8.5 mM<sup>–1</sup> s<sup>–1</sup> in HEPES
buffer), due to hydrophobic interactions between the chelate and serum
proteins. The isoquinoline core allows for the optimization of the
optical properties of the luminescent lanthanide complexes in comparison
to the pyridinic analogues and provides significant shifts of the
excitation energies toward lower values which therefore become more
adapted for biological applications. <b>L2</b> and <b>L3</b> bear two methoxy substituents on the aromatic core in ortho and
para positions, respectively, that further modulate their electronic
structure. The Nd<sup>3+</sup> and Yb<sup>3+</sup> complexes of the
ligand <b>L3</b>, which incorporates the <i>p</i>-dimethoxyisoquinoline
moiety, can be excited up to 420 nm. This wavelength is shifted over
100 nm toward lower energy in comparison to the pyridine-based analogue.
The luminescence quantum yields of the Nd<sup>3+</sup> (0.013–0.016%)
and Yb<sup>3+</sup> chelates (0.028–0.040%) are in the range
of the best nonhydrated complexes, despite the presence of two inner
sphere water molecules. More importantly, the 980 nm NIR emission
band of Yb<b>L3</b> was detected with a good sensitivity in
a proof of concept microscopy experiment at a concentration of 10
μM in fetal bovine serum. Our results demonstrate that even
bishydrated NIR lanthanide complexes can emit a sufficient number
of photons to ensure sensitive detection in practical applications.
In particular, these ligands containing an aromatic core with coordinating
pyridine nitrogen can be easily modified to tune the optical properties
of the NIR luminescent lanthanide complexes while retaining good complex
stability and MRI characteristics for the Gd<sup>3+</sup> analogues.
They constitute a highly versatile platform for the development of
bimodal MR and optical imaging probes based on a simple mixture of
Gd<sup>3+</sup> and Yb<sup>3+</sup>/Nd<sup>3+</sup> complexes using
an identical chelator. Given the presence of two inner sphere water
molecules, important for MRI applications of the corresponding Gd<sup>3+</sup> analogues, this result is particularly exciting and opens
wide perspectives not only for NIR imaging based on Ln<sup>3+</sup> ions but also for the design of combined NIR optical and MRI probes
Rational Design, Pharmacomodulation, and Synthesis of Dual 5‑Hydroxytryptamine 7 (5-HT<sub>7</sub>)/5-Hydroxytryptamine 2A (5-HT<sub>2A</sub>) Receptor Antagonists and Evaluation by [<sup>18</sup>F]-PET Imaging in a Primate Brain
We
report the synthesis of 46 tertiary amine-bearing <i>N</i>-alkylated benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones,
oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones
and <i>N</i>,<i>N</i>′-dialkylated benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones. These compounds
were evaluated against 5-HT<sub>7</sub>R, 5-HT<sub>2A</sub>R, 5-HT<sub>1A</sub>R, and 5-HT<sub>6</sub>R as potent dual 5-HT<sub>7</sub>/5-HT<sub>2A</sub> serotonin receptors ligands. A thorough study of the structure–activity
relationship of the aromatic rings and their substituents, the alkyl
chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>79</b>) and 1-(6-(4-(4-fluorobenzoyl)piperidin-1-yl)hexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>81</b>) were identified as full antagonist ligands
on cyclic adenosine monophosphate (cAMP, <i>K</i><sub>B</sub> = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, <i>K</i><sub>B</sub> = 0.6 and 16 nM, respectively) signaling pathways
of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Both antagonists crossed
the blood–brain barrier as evaluated with [<sup>18</sup>F]
radiolabeled compounds <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> in a primate’s central nervous system using positron emission
tomography. Both radioligands showed standard uptake values ranging
from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent
with 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R in the CNS
PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β‑Amyloid Plaques
In
an effort toward the visualization of β-amyloid plaques
by in vivo imaging techniques, we have conjugated an optimized derivative
of the Pittsburgh compound B (PiB), a well-established marker of Aβ
plaques, to DO3A-monoamide that is capable of forming stable, noncharged
complexes with different trivalent metal ions including Gd<sup>3+</sup> for MRI and <sup>111</sup>In<sup>3+</sup> for SPECT applications.
Proton relaxivity measurements evidenced binding of Gd(DO3A-PiB) to
the amyloid peptide Aβ<sub>1–40</sub> and to human serum
albumin, resulting in a two- and four-fold relaxivity increase, respectively.
Ex vivo immunohistochemical studies showed that the DO3A-PiB complexes
selectively target Aβ plaques on Alzheimer’s disease
human brain tissue. Ex vivo biodistribution data obtained for the <sup>111</sup>In-analogue pointed to a moderate blood–brain barrier
(BBB) penetration in adult male Swiss mice (without amyloid deposits)
with 0.36% ID/g in the cortex at 2 min postinjection